Whatever Happened to Human Experimentation?
By Carl Elliott,
Hastings Center Report
| 01. 01. 2016
Untitled Document
Several years ago, the University of Minnesota hosted a lecture by Alan Milstein, a Philadelphia attorney specializing in clinical trial litigation. Milstein, who does not mince words, insisted on calling research studies “experiments.” “Don’t call it a study,” Milstein said. “Don’t call it a clinical trial. Call it what it is. It’s an experiment.”
Milstein’s comments made me wonder: when was the last time I heard an ongoing research study described as a “human experiment”? The phrase is now almost always associated with abuses. Ask people what they think of when they hear the phrase “human experimentation” and chances are they will reply, “Nazis.” James Jones gave his book Bad Blood the subtitle The Tuskegee Syphilis Experiment. Philip Zimbardo’s controversial study on the psychology of imprisonment is commonly referred to as “The Stanford Prison Experiment.” New Zealand’s most notorious research scandal, on women with cervical carcinoma in situ at Auckland Women’s Hospital, is known colloquially as “The Unfortunate Experiment.” Asking a prospective subject to sign up for a medical experiment would probably get roughly the same response...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...